For the quarter ending 2025-12-31, XAIR had $2,968K increase in cash & cash equivalents over the period. -$4,253K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | -7,630 | -8,258 | -8,078 |
| Depreciation | 746 | 769 | 754 |
| Amortization of licensed right to use technology | 51 | 51 | 51 |
| Stock-based compensation | 1,503 | 1,775 | 1,577 |
| Amortization of debt discount and accretion of debt issuance costs | 212 | 79 | 54 |
| Foreign currency adjustments | - | 10 | 128 |
| Change in fair value of warrant liability | -52 | -1 | 17 |
| Change in fair value of derivative liability | 483 | - | - |
| Amortization of operating lease assets | 95 | 96 | 121 |
| Paid in kind interest | 461 | 448 | 389 |
| Provision for inventory losses | 247 | 135 | 104 |
| Foreign currency adjustments | 146 | - | - |
| Loss on disposal of fixed assets | -359 | -46 | -11 |
| Unrealized gain in marketable securities | 13 | -5 | 9 |
| Inventory | -424 | -304 | -188 |
| Accounts receivable | 260 | 88 | 94 |
| Other current assets and prepaid expenses | 66 | -324 | -617 |
| Accounts payable | -90 | 673 | -708 |
| Accrued expenses | 348 | -682 | 691 |
| Change in fair value of derivative liability | - | - | 0 |
| Operating lease liabilities | -95 | -121 | -49 |
| Net cash used in operating activities | -4,219 | -4,453 | -4,526 |
| Purchase of marketable securities | 4,009 | 0 | 3 |
| Proceeds from sale of marketable securities | 0 | 486 | 777 |
| Purchase of property and equipment | 34 | 246 | 198 |
| Net cash provided by (used in) investing activities | -4,043 | 240 | 576 |
| Proceeds from issuance of common stock through at the market offerings | 0 | 5,694 | 2,441 |
| Proceeds from the sale of common stock of neuronos | 200 | 500 | - |
| Proceeds from issuance of common stock through exercise of warrants | 1 | 2,868 | - |
| Issuance of common stock warrants | 0 | 90 | - |
| Proceeds from long-term loan | 12,000 | 0 | 2,000 |
| Debt issuance costs | 996 | - | - |
| Payment of loans | 0 | 234 | 375 |
| Net cash provided by financing activities | 11,205 | 8,918 | 4,066 |
| Effect of exchange rate changes on cash and cash equivalents | 25 | 18 | 127 |
| Increase in cash, cash equivalents and restricted cash | 2,968 | 4,723 | 243 |
| Cash and cash equivalents at beginning of period | 9,862 | 4,896 | - |
| Cash and cash equivalents at end of period | 12,830 | 9,862 | - |
Beyond Air, Inc. (XAIR)
Beyond Air, Inc. (XAIR)